Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Scotiabank Initiates Coverage On Protara Therapeutics with Sector Outperform Rating, Announces Price Target of $12

Author: Benzinga Newsdesk | April 16, 2025 06:47am
Scotiabank analyst George Farmer initiates coverage on Protara Therapeutics (NASDAQ:TARA) with a Sector Outperform rating and announces Price Target of $12.

Posted In: TARA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist